Circulating Serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as Biomarkers in Patients with Testicular Germ Cell Cancer

Journal of Urology

Volumn 193, Issue 1, 2015, Pages 331-337

  Syring, Isabella ^a   Bartels, Joanna ^a   Holdenrieder, Stefan ^a   Kristiansen, Glen ^a   Müller, Stefan C ^a   Ellinger, Jörg ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

biological; microRNAs; serum; testicular germ cell tumor; testis; tumor markers

Indexed keywords

ALPHA FETOPROTEIN; BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN; MICRORNA; MICRORNA 302A; MICRORNA 302B; MICRORNA 302C; MICRORNA 367; MICRORNA 371A; MICRORNA 372; MICRORNA 373; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; GERM CELL TUMOR; HUMAN; MALE; METASTASIS; MOLECULAR DIAGNOSIS; NON SEMINOMATOUS GERMINOMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SEMINOMA; SENSITIVITY AND SPECIFICITY; TESTIS NONSEMINOMA CANCER; BLOOD; NEOPLASM; PATHOLOGY; TESTIS TUMOR;

HUMANS; MALE; MICRORNAS; NEOPLASMS, GERM CELL AND EMBRYONAL; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84925600621     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2014.07.010     Document Type: Article

References (24)

1. 1 Farazi, T.A., Hoell, J.I., Morozov, P., et al. MicroRNAs in human cancer. Adv Exp Med Biol, 774, 2013, 1.
2. 2 Esteller, M., Non-coding RNAs in human disease. Nat Rev Genet, 12, 2011, 861.
3. 3 Schaefer, A., Jung, M., Kristiansen, G., et al. MicroRNAs and cancer: current state and future perspectives in urologic oncology. Urol Oncol, 28, 2010, 4.
4. 4 Volinia, S., Calin, G.A., Liu, C.G., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A, 103, 2006, 2257.
5. 5 Weber, J.A., Baxter, D.H., Zhang, S., et al. The microRNA spectrum in 12 body fluids. Clin Chem, 56, 2010, 1733.
6. 6 Chim, S.S., Shing, T.K., Hung, E.C., et al. Detection and characterization of placental microRNAs in maternal plasma. Clin Chem, 54, 2008, 482.
7. 7 Chen, X., Ba, Y., Ma, L., et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res, 18, 2008, 997.
8. 8 Scheffer, A.R., Holdenrieder, S., Kristiansen, G., et al. Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer?. World J Urol, 32, 2014, 353.
9. 9 Heneghan, H.M., Miller, N., Lowery, A.J., et al. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg, 251, 2010, 499.
10. 10 Tsujiura, M., Ichikawa, D., Komatsu, S., et al. Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer, 102, 2010, 1174.
11. 11 Hu, Z., Chen, X., Zhao, Y., et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol, 28, 2010, 1721.
12. 12 Mahn, R., Heukamp, L.C., Rogenhofer, S., et al. Circulating microRNAs (miRNA) in serum of patients with prostate cancer. Urology, 77, 2011, 1265 e9.
13. 13 Wulfken, L.M., Moritz, R., Ohlmann, C., et al. MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels. PLoS One, 6, 2011, e25787.
14. 14 Gillis, A.J., Stoop, H.J., Hersmus, R., et al. High-throughput microRNAome analysis in human germ cell tumours. J Pathol, 213, 2007, 319.
15. 15 Murray, M.J., Saini, H.K., van Dongen, S., et al. The two most common histological subtypes of malignant germ cell tumour are distinguished by global microRNA profiles, associated with differential transcription factor expression. Mol Cancer, 9, 2010, 290.
16. 16 Palmer, R.D., Murray, M.J., Saini, H.K., et al. Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets. Cancer Res, 70, 2010, 2911.
17. 17 Voorhoeve, P.M., le Sage, C., Schrier, M., et al. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell, 124, 2006, 1169.
18. 18 Zhou, A.D., Diao, L.T., Xu, H., et al. beta-Catenin/LEF1 transactivates the microRNA-371-373 cluster that modulates the Wnt/beta-catenin-signaling pathway. Oncogene, 31, 2012, 2968.
19. 19 Murray, M.J., Halsall, D.J., Hook, C.E., et al. Identification of microRNAs From the miR-371∼373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumors. Am J Clin Pathol, 135, 2011, 119.
20. 20 Dieckmann, K.P., Spiekermann, M., Balks, T., et al. MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours. Br J Cancer, 107, 2012, 1754.
21. 21 Belge, G., Dieckmann, K.P., Spiekermann, M., et al. Serum levels of microRNAs miR-371-3: a novel class of serum biomarkers for testicular germ cell tumors?. Eur Urol, 61, 2012, 1068.
22. 22 Sanders, I., Holdenrieder, S., Walgenbach-Brunagel, G., et al. Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma. Int J Urol, 19, 2012, 1017.
23. 23 Murray, M.J., Coleman, N., Testicular cancer: a new generation of biomarkers for malignant germ cell tumours. Nat Rev Urol, 9, 2012, 298.
24. 24 Gillis, A.J., Rijlaarsdam, M.A., Eini, R., et al. Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: a proof of principle. Mol Oncol, 7, 2013, 1083.